Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myélome Experience | Zendy

Hervé AvetLoiseau | Zendy; Cyrille Hulin | Zendy; L. Campion | Zendy; Philippe Rodon | Zendy; Gérald Marit | Zendy; Michel Attal | Zendy; Bruno Royer | Zendy; Mamoun Dib | Zendy; Laurent Voillat | Zendy; Didier Bouscary | Zendy; Denis Caillot | Zendy; Marc Wetterwald | Zendy; Brigitte Pegourié | Zendy; G. Lepeu | Zendy; Bernadette Corront | Zendy; Lionel Karlin | Zendy; AnneMarie Stoppa | Zendy; JeanGabriel Fuzibet | Zendy; X. Delbrel | Zendy; François Guilhot | Zendy; Brigitte Kolb | Zendy; Olivier Decaux | Zendy; Thierry Lamy | Zendy; Laurent Garderet | Zendy; Olivier Allangba | Zendy; François Lifermann | Zendy; Bruno Anglaret | Zendy; Philippe Moreau | Zendy; JeanLuc Harousseau | Zendy; Thierry Façon | Zendy

Open Access

Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myélome Experience

Author(s) -

Hervé AvetLoiseau,

Cyrille Hulin,

L. Campion,

Philippe Rodon,

Gérald Marit,

Michel Attal,

Bruno Royer,

Mamoun Dib,

Laurent Voillat,

Didier Bouscary,

Denis Caillot,

Marc Wetterwald,

Brigitte Pegourié,

G. Lepeu,

Bernadette Corront,

Lionel Karlin,

AnneMarie Stoppa,

JeanGabriel Fuzibet,

X. Delbrel,

François Guilhot,

Brigitte Kolb,

Olivier Decaux,

Thierry Lamy,

Laurent Garderet,

Olivier Allangba,

François Lifermann,

Bruno Anglaret,

Philippe Moreau,

JeanLuc Harousseau,

Thierry Façon

Publication year - 2013

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.46.2598

Subject(s) - medicine , multiple myeloma , chemotherapy , melphalan , incidence (geometry) , prednisone , oncology , surgery , optics , physics

Chromosomal abnormalities, especially t(4;14) and del(17p), are major prognostic factors in patients with multiple myeloma (MM). However, this has been especially demonstrated in patients age < 66 years treated with intensive approaches. The goal of this study was to address this issue in elderly patients treated with conventional-dose chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research